# Therapeutic Options for CRAB

> **NCT06440304** · PHASE4 · RECRUITING · sponsor: **Clinical Hospital Centre Zagreb** · enrollment: 108 (estimated)

## Conditions studied

- Infections, Bacterial
- Sepsis Bacterial

## Interventions

- **DRUG:** Fosfomycin
- **DRUG:** Eravacycline
- **DRUG:** ampicillin/sulbactam

## Key facts

- **NCT ID:** NCT06440304
- **Lead sponsor:** Clinical Hospital Centre Zagreb
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-30
- **Primary completion:** 2026-12
- **Final completion:** 2027-02
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06440304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06440304, "Therapeutic Options for CRAB". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06440304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*